Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio-economic factors.


Journal

Alimentary pharmacology & therapeutics
ISSN: 1365-2036
Titre abrégé: Aliment Pharmacol Ther
Pays: England
ID NLM: 8707234

Informations de publication

Date de publication:
03 2019
Historique:
received: 24 09 2018
revised: 22 10 2018
accepted: 30 11 2018
pubmed: 22 1 2019
medline: 4 3 2020
entrez: 22 1 2019
Statut: ppublish

Résumé

Race, ethnicity and socio-economic status impact clinical outcomes in inflammatory bowel disease (IBD) patients. However, their impact on disability has not been studied. To determine the association between race, ethnicity and socio-economic factors with disability in IBD, using the validated IBD disability index (IBD-DI). Ambulatory IBD patients were enrolled at five academic centres participating in the New York Crohn's and Colitis Organization. We assessed the IBD-DI, and collected clinical and socio-economic data. Factors associated with moderate-to-severe disability (IBD-DI score > 35) on univariable analysis were tested in multivariable models with adjusted odds ratios (aOR) and 95% confidence intervals (CI) reported. In this study, 323 patients (57.3% CD, 51.4% female) were enrolled; 17.7% were Hispanic, 17% were non-Hispanic black, 56.0% were non-Hispanic Caucasian and 9.3% belonged to non-Hispanic non-black minority races. However, 39.0% of patients were publicly insured and 38.4% of patients had low annual household income (<$50 000). 100 (31.0%) patients reported moderate-to-severe disability. On multivariable analysis, Hispanic ethnicity (aOR 2.7, 95% CI 1.3-5.6), non-Hispanic non-black minority race (aOR 3.5, 95% CI 1.3-8.9), public payer (aOR 2.1, 95% CI 1.1-4.0) and low annual household income (aOR 3.0, 95% CI 1.7-5.4) were associated with moderate-to-severe disability controlling for disease characteristics. IBD patients who are minorities, have public insurance, or low household income, are 2-3 times more likely to report moderate-to-severe disability independent of disease characteristics in the United States. Future studies are needed to study their complex relationship and to mitigate disability.

Sections du résumé

BACKGROUND
Race, ethnicity and socio-economic status impact clinical outcomes in inflammatory bowel disease (IBD) patients. However, their impact on disability has not been studied.
AIM
To determine the association between race, ethnicity and socio-economic factors with disability in IBD, using the validated IBD disability index (IBD-DI).
METHODS
Ambulatory IBD patients were enrolled at five academic centres participating in the New York Crohn's and Colitis Organization. We assessed the IBD-DI, and collected clinical and socio-economic data. Factors associated with moderate-to-severe disability (IBD-DI score > 35) on univariable analysis were tested in multivariable models with adjusted odds ratios (aOR) and 95% confidence intervals (CI) reported.
RESULTS
In this study, 323 patients (57.3% CD, 51.4% female) were enrolled; 17.7% were Hispanic, 17% were non-Hispanic black, 56.0% were non-Hispanic Caucasian and 9.3% belonged to non-Hispanic non-black minority races. However, 39.0% of patients were publicly insured and 38.4% of patients had low annual household income (<$50 000). 100 (31.0%) patients reported moderate-to-severe disability. On multivariable analysis, Hispanic ethnicity (aOR 2.7, 95% CI 1.3-5.6), non-Hispanic non-black minority race (aOR 3.5, 95% CI 1.3-8.9), public payer (aOR 2.1, 95% CI 1.1-4.0) and low annual household income (aOR 3.0, 95% CI 1.7-5.4) were associated with moderate-to-severe disability controlling for disease characteristics.
CONCLUSIONS
IBD patients who are minorities, have public insurance, or low household income, are 2-3 times more likely to report moderate-to-severe disability independent of disease characteristics in the United States. Future studies are needed to study their complex relationship and to mitigate disability.

Identifiants

pubmed: 30663075
doi: 10.1111/apt.15107
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

564-571

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002384
Pays : United States
Organisme : Crohn's and Colitis Foundation
Pays : International

Informations de copyright

© 2019 John Wiley & Sons Ltd.

Auteurs

Manasi Agrawal (M)

Division of Gastroenterology, Montefiore Medical Center, Bronx, New York.
Division of Gastroenterology, Lenox Hill Hospital, New York, New York.

Shirley Cohen-Mekelburg (S)

Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.

Maia Kayal (M)

Division of Gastroenterology, Mount Sinai Hospital, New York, New York.

Jordan Axelrad (J)

Division of Gastroenterology and Hepatology, Columbia University Medical Center, New York, New York.
Division of Gastroenterology and Hepatology, New York University Langone Medical Center, New York, New York.

Jonathan Galati (J)

Division of Gastroenterology and Hepatology, Weil Cornell Medical Center, New York, New York.

Brad Tricomi (B)

Albert Einstein College of Medicine, Bronx, New York.

Kanika Kamal (K)

Division of Gastroenterology, Mount Sinai Hospital, New York, New York.

Adam S Faye (AS)

Division of Gastroenterology and Hepatology, Columbia University Medical Center, New York, New York.

Paul Abrudescu (P)

Division of Gastroenterology and Hepatology, Northwell University, Long Island, New York.

Ellen Scherl (E)

Division of Gastroenterology and Hepatology, Weil Cornell Medical Center, New York, New York.

Garrett Lawlor (G)

Division of Gastroenterology and Hepatology, Columbia University Medical Center, New York, New York.

Keith Sultan (K)

Division of Gastroenterology and Hepatology, Northwell University, Long Island, New York.

Dana Lukin (D)

Division of Gastroenterology, Montefiore Medical Center, Bronx, New York.
Division of Gastroenterology and Hepatology, Weil Cornell Medical Center, New York, New York.

Jean-Frederic Colombel (JF)

Division of Gastroenterology, Mount Sinai Hospital, New York, New York.

Ryan C Ungaro (RC)

Division of Gastroenterology, Mount Sinai Hospital, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH